Sana Corp (SANA) - Rasio kapitalisasi marang bathi resik

Lambang korporat lan logo Sana Biotechnology Inc (SANA)

High scientific risks at Sana Biotechnology (SANA) create volatility, as evidenced by the P/E ratio. The -4.10 mark reflects the latest market valuation data. Stability will be provided by the universal cell platform for treating diabetes and cancer, while growth potential is embedded in innovative in vivo drugs currently at the start of clinical trials.

SANA sana.com: Koefisien rega marang bathi ing interval 04.07.2022 - 14.11.2026

Rincian metrik komprehensif lan analitis Sana Bio (SANA)

- rega pasar lan target rega analis:
Rega bursa sana.com|SANA - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Kapitalisasi pasar Sana Biotechnology, Inc.|SANA - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data nilai buku modal saham:
Nilai Aset Bersih saben Saham Sana Biotechnology|SANA - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku sana.com|SANA - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Sana Biotechnology|SANA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Sana Corp|SANA - Utang perusahaan|Rasio utang marang kapitalisasi buku Sana Biotechnology, Inc.|SANA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Sana Biotechnology|Rasio jangkoan perantara sana.com
- data bathi bisnis lan rasio investasi:
SANA - Bathi resik|Proyeksi bathi resik Sana Biotechnology|SANA - Pangali P/E|Rasio prakiraan rega marang bathi Sana Biotechnology Inc|SANA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Sana Biotechnology, Inc.|SANA - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Sana Biotechnology|SANA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan sana.com|SANA - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Sana Biotechnology
- rincian pendapatan lan dodolan emiten:
SANA - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan sana.com|SANA - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Sana Biotechnology, Inc.
Analisis komprehensif perusahaan:sana.com
Produk mawa merek Sana Biotechnology, Inc.

The P/E ratio reflects the market value of a single unit of profit, allowing investors to determine the extent of an asset's overvaluation or identify hidden fundamental risks. By analyzing the average P/E of the company, market participants assess the capitalization potential of Sana Biotechnology (SANA), whose ambitions in living tissue programming and in vivo organ regeneration render classic earnings valuations secondary to the value of future breakthrough innovations.

Analisis perusahaan pesaing

Kapitalisasi marang bathi legendbiotech.com LEGN|Pangali P/E AUTL|Allogene Therapeutics, Inc. (ALLO) - Rasio kapitalisasi marang bathi resik|Cartesian Therapeutics Inc - Koefisien rega marang bathi|Cellectis SA (CLLS) - Kapitalisasi marang bathi|CRBU: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik TIL (instilbio.com)|GNTA: Pangali P/E|Koefisien rega marang bathi Century Therapeutics, Inc.|JSPR (Jasper Therapeutics Inc) - Pangali P/E|Kapitalisasi marang bathi Senti Biosciences Inc SNTI|Rasio rega marang bathi Adaptimmune (ADAP)|Rasio rega marang bathi CERO (cero.bio)|Rasio rega marang bathi Alaunos Therapeutics, Inc. TCRT|Achilles Therapeutics PLC - Rasio rega marang bathi|CRGX: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PSTX (Poseida Corp)|TSVT: Pangali P/E|Rasio kapitalisasi marang bathi resik gracellbio.com GRCL